Hebe dich für diese Rolle von der Masse ab — erstelle in etwa einer Minute einen maßgeschneiderten Lebenslauf und ein Anschreiben.
Axolabs is a business unit of LGC, a leading CRO/CDMO in oligonucleotide discovery and development, based in Kulmbach, Germany. The Director Business Development will define and drive the BD strategy and lead a team to grow Axolabs' services across Europe.
The role requires deep knowledge of pharmaceutical development, strong networking at senior levels, and the ability to shape proposals and partnerships with biotech and pharma clients worldwide.
The Director Business Development – Axolabs (CRO) will be instrumental in defining and driving Axolabs’ business development strategy. Directing a Business Development team the successful candidate will play a key role in delivering Axolabs’ business growth aspiration. Extending brand recognition within the associated client base the successful candidate will provide frontline interactions with biotechnology and pharmaceutical companies across Europe, with the opportunity to contribute to business activities in US and Asia.
The role offers a unique opportunity for an individual that possesses strong scientific and problem-solving skills, deep knowledge of the pharmaceutical development process, the ability to network at senior levels in client organisations and a good business acumen.
Reporting to the Axolabs CRO Managing Director, the Director Business Development will be part of the extended leadership team.
This position requires knowledge and experience in business development in the pharmaceutical and biotechnology sector, good industry networks and deep exposure to drug development projects, ideally in the field of Nucleic Acid Therapeutics.
LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Its high-quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for their performance, quality, and range.
LGC strongly believes that every job applicant and employee should be valued for their individual talents regardless of age, disability, race, color, ethnic or national origin, sex, sexual orientation, gender reassignment, marital or civil partnership, pregnancy or maternity, religion, or belief. Short listing, interviewing and selection will always be carried out without regard to gender, sexual orientation, marital status, color, race, nationality, ethnic or national origins, religion or belief, age, or trade union membership.
For more information about LGC, please visit our website www.lgcgroup.com
scienceforasaferworld
Axolabs is a business unit of LGC, and a leading provider of CRO/CDMO capabilities to the therapeutic oligonucleotide discovery and development industry. Centred out of LGC’s site in Kulmbach, Germany, Axolabs works closely with its customers to assist the identification and development of lead candidates with a broad suite of bioinformatics, biology, chemistry, manufacturing and analytical services that support discovery, pre-clinical and clinical trials and scale-up manufacture. With a track record in Nucleic Acid Therapeutics that traces back more than 25 years, Axolabs provides deep knowledge and expertise in the services it provides, working collaboratively and responsively with its clients to assist them in achieving their …